We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go: Expired investment: £1,146,318
Beatstream allows users to listen live to bars, clubs and music venues all around the UK using it's music streaming app that's entirely venue centric. Beatstream also gives artists the opportunity to showcase their music and creativity without having to get people to invest by buying a ticket.
days to go: Expired investment: £32,240
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go: Expired investment: £543,670
Big Couch is the 'crewfunding' platform that empowers filmmakers to connect with crews that invest in projects they believe in. Crews accept lower upfront fees in return for profit shares and deferred payment. Film producers optimise their budgets up to 20%. 
days to go: Expired investment: £403
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
The story of Laurie Cunningham, the first black footballer to play for England
days to go: Expired investment: £80
Founded by Sadie Frost and Emma Comley in 2011 and incorporated Feb 2012, Blonde To Black’s aim is to create original screenplays and nurture new talent. Having already shot two feature films 'Buttercup Bill' and ‘Set The Thames On Fire’ and 4 short films the company is going from strength to strength. There are 5 further features and 3 shorts in development. “Invisibles" is aimed to shoot winter 2015 and cast Craig Roberts (Submarine, 22 Jump St) and George Mackay (Pride, Defiance).
days to go: Expired investment: £1,113
BlueJay are a social radio which allow the user to create their very own livestream playlist which they can share with a small group of friends or thousands of followers. BlueJay is a free music app available on Android and IOS and allows users to share their own music or follow their favourite artists or friends to discover new music. 
days to go: Expired investment: £153,788
BOS Films specialises in creating and producing african themed films for mainstream audiences. The Directors first film, a love story about immigration, was a big success. It screened across the world, in the UK and the US and was also released in Africa.
days to go: Expired investment: £1,560
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
days to go: Expired investment: £520,294
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph